These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 1715488)
1. Effects of antihypertensive drug classes on regression of connective tissue components of hypertension. Keeley FW; Elmoselhi A; Leenen FH J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S64-9. PubMed ID: 1715488 [TBL] [Abstract][Full Text] [Related]
2. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone. Han WQ; Wu LY; Zhou HY; Zhang J; Che ZQ; Wu YJ; Liu JJ; Zhu DL; Gao PJ Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):583-8. PubMed ID: 19673944 [TBL] [Abstract][Full Text] [Related]
3. [Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]. Agabiti-Rosei E Drugs; 2003; 63 Spec No 1():19-29. PubMed ID: 12708883 [TBL] [Abstract][Full Text] [Related]
4. [Drugs and arterial stiffness in hypertensive patients]. Laurent S Drugs; 2003; 63 Spec No 1():1-8. PubMed ID: 12708878 [TBL] [Abstract][Full Text] [Related]
6. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension. Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE; Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761 [TBL] [Abstract][Full Text] [Related]
7. [Are all antihypertensive drugs renoprotective?]. Wolf S; Risler T Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950 [TBL] [Abstract][Full Text] [Related]
8. Response of aortic elastin synthesis and accumulation to developing hypertension and the inhibitory effect of colchicine on this response. Keeley FW; Alatawi A Lab Invest; 1991 Apr; 64(4):499-507. PubMed ID: 2016856 [TBL] [Abstract][Full Text] [Related]
9. Antihypertension and anti-cardiovascular remodeling by phenylalanine in spontaneously hypertensive rats: effectiveness and mechanisms. Zhao G; Li Z; Gu T Chin Med J (Engl); 2001 Mar; 114(3):270-4. PubMed ID: 11780312 [TBL] [Abstract][Full Text] [Related]
10. The future of antihypertensive treatment. Israili ZH; Hernández-Hernández R; Valasco M Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579 [TBL] [Abstract][Full Text] [Related]
11. Baroreflexes and cardiovascular regulation in hypertension. Head GA J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S7-16. PubMed ID: 8642810 [TBL] [Abstract][Full Text] [Related]
12. [Structural and functional reconfiguration of large arteries in hypertensive disease: a role of connective tissue metabolic disturbances]. Polivoda SN; Cherepok AA; Sychev RA Klin Med (Mosk); 2004; 82(8):30-3. PubMed ID: 15468721 [TBL] [Abstract][Full Text] [Related]
13. Effect of angiotensin II blockade on cardiac hypertrophy and remodelling: a review. Dahlöf B J Hum Hypertens; 1995 Nov; 9 Suppl 5():S37-44. PubMed ID: 8583480 [TBL] [Abstract][Full Text] [Related]
14. In vivo and in vitro effects of nebivolol on penile structures in hypertensive rats. Toblli JE; Cao G; Casas G; Mazza ON Am J Hypertens; 2006 Dec; 19(12):1226-32. PubMed ID: 17161767 [TBL] [Abstract][Full Text] [Related]
15. [Effect of carbon disulfide on the metabolism of connective tissue of rats' aorta and lungs]. Wegrowski J Med Pr; 1980; 31(1):13-9. PubMed ID: 7374431 [TBL] [Abstract][Full Text] [Related]
16. Differential expression of elastin and alpha 1(I) collagen mRNA in mice with bleomycin-induced pulmonary fibrosis. Lucey EC; Ngo HQ; Agarwal A; Smith BD; Snider GL; Goldstein RH Lab Invest; 1996 Jan; 74(1):12-20. PubMed ID: 8569173 [TBL] [Abstract][Full Text] [Related]
17. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study. Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006 [TBL] [Abstract][Full Text] [Related]
18. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment]. Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399 [TBL] [Abstract][Full Text] [Related]
19. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration. J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138 [TBL] [Abstract][Full Text] [Related]
20. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs. Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]